APD
52
-2
TJX
51
-3
AIZ
59
5
ADT
53
2
CINF
47
12
LH
45
2
HBAN
57
-2
D
37
-3
ESS
57
-5
IP
62
5
WFC
75
-2
COST
48
-3
WMB
68
2
ACN
38
-18
NUE
48
-3
NEE
52
-2
ORLY
57
-3
GLW
52
-7
MAS
58
-4
HCA
48
-2
APD
52
-2
TJX
51
-3
AIZ
59
5
ADT
53
2
CINF
47
12
LH
45
2
HBAN
57
-2
D
37
-3
ESS
57
-5
IP
62
5
WFC
75
-2
COST
48
-3
WMB
68
2
ACN
38
-18
NUE
48
-3
NEE
52
-2
ORLY
57
-3
GLW
52
-7
MAS
58
-4
HCA
48
-2
Financhill
Back

AstraZeneca PLC 10K Form

Sell
41

AZN
AstraZeneca PLC

Last Price:
71.14
Seasonality Move:
1.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AZN News And Ratings

See the #1 stock for the next 7 days that we like better than AZN

AZN Financial Statistics

Sales & Book Value

Annual Sales: $45.81B
Cash Flow: $2.42B
Price / Cash Flow: 32.66
Annual Sales: $12.74
Price / Book: 5.72

Profitability

EPS (TTM): 2.07000
Net Income (TTM): $6.44B
Gross Margin: $37.54B
Return on Equity: 16.87%
Return on Assets: 6.44%

AstraZeneca PLC Earnings Forecast

Key AstraZeneca PLC Financial Ratios

  • The Gross Profit Margin over the past 26 years for AZN is 81.95%.
  • The Selling, General & Administrative Expenses for AZN have been equal to 39.78% of Gross Profit Margin.
  • The Research & Development expenses have been 23.87% of Revenue.
  • The Interest Expense is 26.68% of Operating Income.
  • The Net Earning history of AZN is 13.00% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 20 years.

AstraZeneca PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AZN
CUSIP: 046353
Website: astrazeneca.com

Debt

Debt-to-Equity Ratio: 0.82
Current Ratio: 0.89
Quick Ratio: 0.69

Price-to-Earnings

Trailing P/E Ratio: 38.24
Forward P/E Ratio: 15.45

AZN Technical Analysis vs Fundamental Analysis

Sell
41
AstraZeneca PLC (AZN) is a Sell

Is AstraZeneca PLC a Buy or a Sell?

  • AstraZeneca PLC stock is rated a Sell
    The current AstraZeneca PLC [AZN] share price is $72.84. The Score for AZN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.